CompletedNot applicableNCT06350461
Impact of Discontinuing Hypertonic Saline in People With CF on Highly Effective CFTR Modulators- A SIMPLIFY Sub-Study
Studying Cystic fibrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Nicole Hamblett
- Principal Investigator
- Nicole Mayer-Hamblett, PhDUniversity of Washington/Seattle Children's
- Intervention
- Discontinuation of hypertonic saline (HS)(other)
- Enrollment
- 370 enrolled
- Eligibility
- 12 years · All sexes
- Timeline
- 2020 – 2022
Study locations (30)
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- Providence Alaska Medical Center, Anchorage, Alaska, United States
- Tucson Cystic Fibrosis Center, Tucson, Arizona, United States
- Arkansas Children's Hospital, Little Rock, Arkansas, United States
- Miller Children's and Women's Hospital Long Beach, Long Beach, California, United States
- CHOC Children's Hospital, Orange, California, United States
- Stanford University Medical Center, Palo Alto, California, United States
- Rady Children's Hospital and Health Center at the University of California San Diego, San Diego, California, United States
- University of California, San Francisco - Adult Center, San Francisco, California, United States
- University of California, San Francisco - Peds Center, San Francisco, California, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
- National Jewish Health, Denver, Colorado, United States
- Yale University School of Medicine, New Haven, Connecticut, United States
- University of Florida, Gainesville, Florida, United States
- Nemours Children's Clinic - Jacksonville, Jacksonville, Florida, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
Cystic Fibrosis Foundation · Dartmouth-Hitchcock Medical Center · University of Washington
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06350461 on ClinicalTrials.govOther trials for Cystic fibrosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT04530383Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel FunctionUniversity of Kansas Medical Center
- RECRUITINGPHASE2NCT07450547Phase 2 Study to Assess the Safety and Efficacy of ANG003Anagram Therapeutics, Inc.
- RECRUITINGPHASE1NCT07437105Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy ParticipantsVertex Pharmaceuticals Incorporated
- RECRUITINGNANCT07436351ACT With CF Self-Help ToolkitThomas Jefferson University
- RECRUITINGNANCT07314229Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-IvacaftorUniversity Hospital, Lille
- RECRUITINGNCT07369414Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households: A Case-control Study of Exposure Risk at HomeResearch Center Borstel
- RECRUITINGNCT07083557Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)Bettina Mittendorfer
- RECRUITINGNCT07505797ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)iSono Health, Inc.